Evaluation of the immunohistochemical expression of p16 in colorectal carcinoma and correlate its expression to different clinical and pathological parameters as patients' ages, sexes, tumor location, histopathological phenotype, status of nodal involvement, perineural and lymphovascular invasion.
Colorectal Carcinoma is very common nowadays, with increasing need for further research. p16 is tumor suppressor gene with a vital rule ; inactivation of p16 leads to tumor formation and progression. 50 Specimens will be collected from Pathology Department of Sohag University Hospital. Sufficient clinical and histopathological data will be attached for each case. The previously processed formalin-fixed, paraffin-embedded tissue blocks will be used to get Hematoxylin \& Eosin stained sections to confirm the diagnosis and to detect the histopathological type, grade and stage of each tumor. Another sliced tissue sections will be immunohistochemically stained with p16 monoclonal antibodies to be evaluated with the positivity, intensity and distribution of the detected stain.
Study Type
OBSERVATIONAL
Enrollment
50
Immunohistochemical staining of paraffin embedded blocks of colorectal carcinoma tissues by p16 monoclonal antibodies to be evaluated with the positivity, intensity and distribution of the detected stain.
Faculty of Medicine
Sohag, Recruiting, Egypt
RECRUITINGEvaluation of p16 Expression in Colorectal Carcinoma.
Immunohistochemical staining of Colorectal tissues by p16 monoclonal antibody
Time frame: 6 months
Correlation of p16 expression to different clinical and pathological parameters
Correlation of p16 expression to different clinical and pathological parameters as patients' ages, sexes, tumor location, histopathological phenotype, status of nodal involvement, perineural and lymphovascular invasion.
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.